Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Fosfomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Tract Infections 2 Infections 2 Urinary Bladder Neoplasms 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1

Interventions

Docetaxel 265 Prednisone 218 enzalutamide 171 Leuprolide 164 Radiotherapy 157 Abiraterone Acetate 152 Magnetic Resonance Spectroscopy 145 bicalutamide 119 Goserelin 117 Androgen Antagonists 107 Radiosurgery 100 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 98 apalutamide 85 gallium 68 PSMA-11 70 abiraterone 68 Specimen Handling 68 darolutamide 58 Gonadotropin-Releasing Hormone 55 Surveys and Questionnaires 53 Biopsy 53 Radiation 52 cabazitaxel 51 Brachytherapy 51 Triptorelin Pamoate 50 Standard of Care 45 pembrolizumab 44 luprolide acetate gel depot 43 Zoledronic Acid 43 Radiotherapy, Intensity-Modulated 42 Estramustine 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡